NCT07261059Not yet recruiting
AI-assisted Integrated Care to Promote Colonoscopy Uptake
Artificial Intelligence-assisted Integrated Care to Promote Colonoscopy Uptake in China: a Cluster Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 3 Dec 2025
Brief summary (registry, in English)
Colorectal cancer (CRC) ranks the second most common cancer and the fourth leading cause of cancer-related deaths in China. Early screening of CRC has been proven to reduce the incidence and mortality, with colonoscopy as the gold standard for CRC screening. This trial aims to evaluate the effectiveness of artificial intelligence-assistant integrated care for improving uptake rate of colonoscopy among high-risk individuals aged 40 to 64 in China. It's a two-arm, parallel cluster randomized controlled trial. The main question it aims to answer is whether the AI-assisted integrated care influence participants' screening-related knowledge, health beliefs, behavioral intention, and uptake of colonoscopy. Participants will: 1. Be recruited and allocated into one of two groups according to the assigned clusters. Participants in one group will be invited to receive usual specialty care. In addition to usual specialty care, participants in the other group will receive AI-assisted integrated care provided by specialist and general practitioners collaboratively. 2. Complete a questionnaire survey on their knowledge, health beliefs, behavioral intention on CRC screening. 3. Have their colonoscopy status checked at the middle and end of trial.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- First submitted
- 21 Nov 2025
- Start date
- 8 Dec 2025
- Primary completion date
- Sept 2026
- Lead sponsor
- Fudan University
- Diseases
- Colorectal cancer
- NCT number
- NCT07261059
What you commit to
- Study type: Interventional
- Planned participants: 400
- From 8 Dec 2025 to the primary completion date, Sept 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of colorectal cancer;
- Contraindications to colonoscopy,(e.g. severe cardiac, cerebral, lung diseases, or renal dysfunction).
Who the study is looking for
- Individuals who test positive on either the Colorectal Cancer Risk Assessment Scale or the fecal immunochemical test (FIT);
- Aged 40 \~ 64 years;
- Proficient in smartphone use and able to engage with the intervention;
- Provided informed consent .
Age in the registry: 40 years to 64 years · Sex: All · Accepts healthy volunteers
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.